Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsChemotherapy, AdjuvantCombined Modality TherapyDoxorubicinCyclophosphamideCisplatinDisease-Free SurvivalTreatment OutcomeVincristinePrognosisOsteosarcomaEtoposideNeoadjuvant TherapySurvival AnalysisBreast NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm StagingLung NeoplasmsMethotrexateSurvival RateCarboplatinOrganoplatinum CompoundsBleomycinVinblastineAntibodies, Monoclonal, HumanizedDrug Administration ScheduleNeoplasm Recurrence, LocalRetrospective StudiesPaclitaxelRadiotherapyTransplantation, AutologousNeoplasmsHodgkin DiseaseCarcinoma, Non-Small-Cell LungSalvage TherapyAntimetabolites, AntineoplasticLymphatic IrradiationNeoplasm MetastasisAntineoplastic Agents, AlkylatingDrug Resistance, NeoplasmAntineoplastic Agents, PhytogenicTaxoidsAntibiotics, AntineoplasticInduction ChemotherapyGranulocyte Colony-Stimulating FactorFollow-Up StudiesColorectal NeoplasmsIfosfamideDeoxycytidineClinical Trials as TopicHematopoietic Stem Cell TransplantationKaplan-Meier EstimateCytarabineAnthracyclinesTime FactorsFluorouracilProspective StudiesHematopoietic Stem Cell MobilizationAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedOvarian NeoplasmsChemotherapy, Cancer, Regional PerfusionClinical ProtocolsAdenocarcinomaVomitingCarcinoma, Squamous CellNauseaNeutropeniaLymphoma, Non-HodgkinCell Line, TumorTesticular NeoplasmsDose-Response Relationship, DrugCarmustineRadiotherapy, AdjuvantLymphoma, Large B-Cell, DiffuseCamptothecinDacarbazineLomustineBrain NeoplasmsMitomycinDaunorubicinMechlorethamineBone NeoplasmsMelphalanInfusions, IntravenousLeukopeniaNeoplasms, Germ Cell and EmbryonalPrednisoneMitoxantroneProcarbazineLiver NeoplasmsPlatinum CompoundsTumor Markers, BiologicalApoptosisInfusions, Intra-ArterialAntiemeticsRecurrenceThiotepaDrug Screening Assays, Antitumor